优势肿瘤同时通过气道扩散影响同步多发原发性肺腺癌的预后。

IF 3 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Tong Qiu, Feng Hou, Jie Wu, Zhe Wu, Wenxing Du, Jichen Yang, Yandong Zhao, Xiangfeng Jin, Zizong Wang, Kaihua Tian, Yi Shen, Haiqing Zhou, Wenjie Jiao
{"title":"优势肿瘤同时通过气道扩散影响同步多发原发性肺腺癌的预后。","authors":"Tong Qiu, Feng Hou, Jie Wu, Zhe Wu, Wenxing Du, Jichen Yang, Yandong Zhao, Xiangfeng Jin, Zizong Wang, Kaihua Tian, Yi Shen, Haiqing Zhou, Wenjie Jiao","doi":"10.1093/ejcts/ezaf163","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The impact of tumour spread through air spaces (STAS) on the prognosis of synchronous multiple primary lung adenocarcinoma (sMPLA) remains unclear. This study evaluates the prognostic significance of STAS in early-stage sMPLA and its combined effect with surgical strategies.</p><p><strong>Methods: </strong>Patients with cT1-3N0M0 sMPLA (2012-2018) were selected based on multidisciplinary team evaluation, surgical confirmation of invasive adenocarcinoma and exclusion of metastases or minimally invasive disease. Prognostic variables were selected using the least absolute shrinkage and selection operator regression with grouped variables. Survival outcomes were analysed via Cox proportional-hazards models for overall survival and Fine & Gray competing risk regression for recurrence-free survival.</p><p><strong>Results: </strong>Among 131 patients, STAS was observed in 68 (51.9%), including 21 (16.0%) with STAS in both tumours (bi-STAS) and 47 (35.9%) with STAS in one tumour. Bi-STAS independently predicted worse overall survival (hazard ratio = 3.78, 95% confidence interval: 1.23-11.65, P = 0.020) and recurrence-free survival (hazard ratio = 3.99, 95% confidence interval: 1.34-11.93, P = 0.013). Patients with bi-STAS had significantly lower overall survival (P < 0.001) and higher cumulative incidence of recurrence (P < 0.001) compared to mono-STAS/un-STAS groups. Notably, bi-STAS patients showed similar survival outcomes whether undergoing lobectomy or sublobar resection (overall survival: P = 0.889; recurrence-free survival: P = 0.857), underscoring limited benefit from extensive surgery.</p><p><strong>Conclusions: </strong>Concurrent bi-STAS is a strong prognostic marker for early-stage sMPLA, independent of surgical strategy. Comprehensive STAS evaluation in all dominant tumours is critical for postoperative risk stratification.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141745/pdf/","citationCount":"0","resultStr":"{\"title\":\"Concurrent spread through air spaces in dominant tumours impacts prognosis in synchronous multiple primary lung adenocarcinoma.\",\"authors\":\"Tong Qiu, Feng Hou, Jie Wu, Zhe Wu, Wenxing Du, Jichen Yang, Yandong Zhao, Xiangfeng Jin, Zizong Wang, Kaihua Tian, Yi Shen, Haiqing Zhou, Wenjie Jiao\",\"doi\":\"10.1093/ejcts/ezaf163\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>The impact of tumour spread through air spaces (STAS) on the prognosis of synchronous multiple primary lung adenocarcinoma (sMPLA) remains unclear. This study evaluates the prognostic significance of STAS in early-stage sMPLA and its combined effect with surgical strategies.</p><p><strong>Methods: </strong>Patients with cT1-3N0M0 sMPLA (2012-2018) were selected based on multidisciplinary team evaluation, surgical confirmation of invasive adenocarcinoma and exclusion of metastases or minimally invasive disease. Prognostic variables were selected using the least absolute shrinkage and selection operator regression with grouped variables. Survival outcomes were analysed via Cox proportional-hazards models for overall survival and Fine & Gray competing risk regression for recurrence-free survival.</p><p><strong>Results: </strong>Among 131 patients, STAS was observed in 68 (51.9%), including 21 (16.0%) with STAS in both tumours (bi-STAS) and 47 (35.9%) with STAS in one tumour. Bi-STAS independently predicted worse overall survival (hazard ratio = 3.78, 95% confidence interval: 1.23-11.65, P = 0.020) and recurrence-free survival (hazard ratio = 3.99, 95% confidence interval: 1.34-11.93, P = 0.013). Patients with bi-STAS had significantly lower overall survival (P < 0.001) and higher cumulative incidence of recurrence (P < 0.001) compared to mono-STAS/un-STAS groups. Notably, bi-STAS patients showed similar survival outcomes whether undergoing lobectomy or sublobar resection (overall survival: P = 0.889; recurrence-free survival: P = 0.857), underscoring limited benefit from extensive surgery.</p><p><strong>Conclusions: </strong>Concurrent bi-STAS is a strong prognostic marker for early-stage sMPLA, independent of surgical strategy. Comprehensive STAS evaluation in all dominant tumours is critical for postoperative risk stratification.</p>\",\"PeriodicalId\":11938,\"journal\":{\"name\":\"European Journal of Cardio-Thoracic Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141745/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cardio-Thoracic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ejcts/ezaf163\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cardio-Thoracic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejcts/ezaf163","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

目的:肿瘤通过空气间隙扩散(STAS)对同步多发原发性肺腺癌(sMPLA)预后的影响尚不清楚。本研究评估STAS在早期sMPLA中的预后意义及其与手术策略的联合作用。方法:选取2012-2018年的cT1-3N0M0型sMPLA患者,根据多学科团队评估、手术确认浸润性腺癌、排除转移或微创性疾病。预后变量选择使用最小的绝对收缩和选择算子回归与分组变量。生存结果通过总生存的Cox比例风险模型和无复发生存的Fine & Gray竞争风险回归进行分析。结果:131例患者中,有68例(51.9%)出现STAS,其中双肿瘤合并STAS 21例(16.0%),单肿瘤合并STAS 47例(35.9%)。Bi-STAS独立预测较差的总生存率(风险比= 3.78,95%可信区间:1.23-11.65,p = 0.020)和无复发生存率(风险比= 3.99,95%可信区间:1.34-11.93,p = 0.013)。结论:两种肿瘤同时存在STAS是早期sMPLA的一个强有力的预后标志,独立于手术策略。所有优势肿瘤的综合STAS评估对术后风险分层至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Concurrent spread through air spaces in dominant tumours impacts prognosis in synchronous multiple primary lung adenocarcinoma.

Objectives: The impact of tumour spread through air spaces (STAS) on the prognosis of synchronous multiple primary lung adenocarcinoma (sMPLA) remains unclear. This study evaluates the prognostic significance of STAS in early-stage sMPLA and its combined effect with surgical strategies.

Methods: Patients with cT1-3N0M0 sMPLA (2012-2018) were selected based on multidisciplinary team evaluation, surgical confirmation of invasive adenocarcinoma and exclusion of metastases or minimally invasive disease. Prognostic variables were selected using the least absolute shrinkage and selection operator regression with grouped variables. Survival outcomes were analysed via Cox proportional-hazards models for overall survival and Fine & Gray competing risk regression for recurrence-free survival.

Results: Among 131 patients, STAS was observed in 68 (51.9%), including 21 (16.0%) with STAS in both tumours (bi-STAS) and 47 (35.9%) with STAS in one tumour. Bi-STAS independently predicted worse overall survival (hazard ratio = 3.78, 95% confidence interval: 1.23-11.65, P = 0.020) and recurrence-free survival (hazard ratio = 3.99, 95% confidence interval: 1.34-11.93, P = 0.013). Patients with bi-STAS had significantly lower overall survival (P < 0.001) and higher cumulative incidence of recurrence (P < 0.001) compared to mono-STAS/un-STAS groups. Notably, bi-STAS patients showed similar survival outcomes whether undergoing lobectomy or sublobar resection (overall survival: P = 0.889; recurrence-free survival: P = 0.857), underscoring limited benefit from extensive surgery.

Conclusions: Concurrent bi-STAS is a strong prognostic marker for early-stage sMPLA, independent of surgical strategy. Comprehensive STAS evaluation in all dominant tumours is critical for postoperative risk stratification.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
11.80%
发文量
564
审稿时长
2 months
期刊介绍: The primary aim of the European Journal of Cardio-Thoracic Surgery is to provide a medium for the publication of high-quality original scientific reports documenting progress in cardiac and thoracic surgery. The journal publishes reports of significant clinical and experimental advances related to surgery of the heart, the great vessels and the chest. The European Journal of Cardio-Thoracic Surgery is an international journal and accepts submissions from all regions. The journal is supported by a number of leading European societies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信